{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T17:21:59Z","timestamp":1788110519163,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd004278","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2008,1,23]],"date-time":"2008-01-23T00:00:00Z","timestamp":1201046400000}}],"reference-count":77,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004278.pub2","type":"journal-article","created":{"date-parts":[[2008,2,6]],"date-time":"2008-02-06T01:11:33Z","timestamp":1202260293000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Haloperidol versus chlorpromazine for schizophrenia"],"prefix":"10.1002","volume":"2013","author":[{"given":"Claudia","family":"Leucht","sequence":"first","affiliation":[{"name":"Technische Universit\u00e4t M\u00fcnchen Klinikum rechts der Isar; Klinik und Poliklinik f\u00fcr Psychiatrie und Psychotherapie; Ismaningerstrasse 22 M\u00fcnchen Germany 81675"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kitzmantel","sequence":"additional","affiliation":[{"name":"Westerm\u00fchlstrasse 11 M\u00fcnchen Germany 80469"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kane","sequence":"additional","affiliation":[{"name":"The Zucker Hillside Hospital; Psychiatry; 75-59 263rd street Glen Oaks New York USA 11004"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Leucht","sequence":"additional","affiliation":[{"name":"Technische Universit\u00e4t M\u00fcnchen Klinikum rechts der Isar; Klinik und Poliklinik f\u00fcr Psychiatrie und Psychotherapie; Ismaningerstrasse 22 M\u00fcnchen Germany 81675"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Lian LC","family":"Chua","sequence":"additional","affiliation":[{"name":"Lynfield Hospital; Craven and Airedale Drugs and Alcohol Team; 25-27 Henry Street Bradford West Yorkshire UK BD21 3DR"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,1,23]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD004278.pub2-BIB0001|cit1","first-page":"127","article-title":"Comparison of IM haloperidol and IM chlorpromazine in the treatment of acutely psychotic patients","volume":"18","author":"Bailine","year":"1981","journal-title":"The Psychiatric Hospital"},{"issue":"2","key":"10.1002\/14651858.CD004278.pub2-BIB0002|cit2","first-page":"70","article-title":"A relation study of the extrapyramidal symptoms, serum prolactin levels and clinical response during treatment of antipsychotics","volume":"20","author":"Bi","year":"1994","journal-title":"Chinese Journal of Nervous and Mental Diseases"},{"issue":"3","key":"10.1002\/14651858.CD004278.pub2-BIB0003|cit3","first-page":"57","article-title":"Haloperidol versus chlorpromazine","volume":"5","author":"Clark","year":"1969","journal-title":"Psychopharmacology Bulletin"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004278.pub2-BIB0004|cit4","first-page":"53","article-title":"Effects of two butyrophenone compounds on acute schizophrenic patients: speculation on the neurophysiologic sites of action","volume":"3","author":"Gallant","year":"1967","journal-title":"International Journal of Neuropsychiatry"},{"key":"10.1002\/14651858.CD004278.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1176\/ajp.121.6.592","article-title":"Trifluperidol and haloperidol in the treatment of acute schizophrenia","volume":"121","author":"Pratt","year":"1964","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004278.pub2-BIB0006|cit6","first-page":"89","article-title":"A comparison of the effects of four major antipsychotic drugs (chlorpromazine, thioproperazine, prochlorpremazine and haloperidol) for paraniod schizophrenia","volume":"3","author":"Lemp\u00e9ri\u00e8re","year":"1962","journal-title":"Neuro-Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD004278.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0033-3182(73)71377-3","article-title":"Rapid tranquilization of acutely psychotic patients with intramuscular haloperidol and chlorpromazine","volume":"14","author":"Man","year":"1973","journal-title":"Psychosomatics"},{"key":"10.1002\/14651858.CD004278.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1192\/bjp.131.3.310","article-title":"High dosage haloperidol in chronic schizophrenia","volume":"131","author":"McCreadie","year":"1977","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004278.pub2-BIB0009|cit9","first-page":"30","article-title":"A comparative trial of zotepine, chlorpromazine and haloperidol in schizophrenic patients","volume":"10","author":"Nishizono","year":"1994","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD004278.pub2-BIB0010|cit10","first-page":"112","article-title":"Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia","volume":"35","author":"Reschke","year":"1974","journal-title":"Diseases of the Nervous System"},{"issue":"1","key":"10.1002\/14651858.CD004278.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1176\/ajp.129.1.78","article-title":"Comparison of injectable haloperidol and chlorpromazine","volume":"129","author":"Ritter","year":"1972","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD004278.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/030006057800600210","article-title":"A comparison of the relative efficacy of Serenace and chlorpromazine in the treatment of chronic schizophrenics","volume":"6","author":"Rompel","year":"1978","journal-title":"Journal of International Medical Research"},{"issue":"1","key":"10.1002\/14651858.CD004278.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00005053-197201000-00005","article-title":"Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia. Chemically unrelated antipsychotics as therapeutic alternatives","volume":"154","author":"Serafetinides","year":"1972","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"9","key":"10.1002\/14651858.CD004278.pub2-BIB0014|cit14","first-page":"561","article-title":"A controlled evaluation of haloperidol, chlorpromazine, and sodium amobarbital: intramuscular short-term use in acute psychotic patients","volume":"11","author":"Shopsin","year":"1969","journal-title":"Current Therapeutic Research"},{"issue":"4","key":"10.1002\/14651858.CD004278.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/00048677509159857","article-title":"Tranquilizers or anti-depressants for chronic schizophrenics: a long term study","volume":"9","author":"Teja","year":"1975","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD004278.pub2-BIB0016|cit16","first-page":"271","article-title":"Efficacy and tolerance of bromperidol decanoate in psychotic patients treated with haloperidol or chlorpromazine","volume":"27","author":"Bernardi","year":"1992","journal-title":"Rivista di Psichiatria"},{"issue":"5-II","key":"10.1002\/14651858.CD004278.pub2-BIB0017|cit17","first-page":"31","article-title":"A comparative longitudinal study of risperidone versus classic neuroleptic drugs in the treatment of schizophrenia: 24 Months observation","volume":"28","author":"Bouchard","year":"2002","journal-title":"Encephale"},{"issue":"3","key":"10.1002\/14651858.CD004278.pub2-BIB0018|cit18","first-page":"264","article-title":"Effects of L-DOPA on pharmacological parkinsonism","volume":"42","author":"Bruno","year":"1965","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"6","key":"10.1002\/14651858.CD004278.pub2-BIB0019|cit19","first-page":"325","article-title":"Clinical observation on schizophrenic patients treated with risperidone","volume":"11","author":"Chen","year":"2001","journal-title":"Journal of Clinical Psychological Medicine"},{"issue":"1","key":"10.1002\/14651858.CD004278.pub2-BIB0020|cit20","first-page":"21","article-title":"A controlled study of tryptophan-benserazide in schizophrenia","volume":"2","author":"Chouinard","year":"1978","journal-title":"Communications in Psychopharmacology"},{"key":"10.1002\/14651858.CD004278.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"S287","DOI":"10.1016\/S0924-977X(99)80341-1","article-title":"Comparison of efficacy of clozapine, sulpiride, chlorpromazine and haloperidol in chronic schizophrenic patients therapy","volume":"9","author":"Cosar","year":"1999","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD004278.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1600-0447.1992.tb01446.x","article-title":"Effects of antipsychotic drugs on memory functions of schizophrenic patients","volume":"85","author":"Eitan","year":"1992","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"487","key":"10.1002\/14651858.CD004278.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1192\/bjp.112.487.633","article-title":"A controlled trial of anti-Parkinson drugs in drug-induced Parkinsonism","volume":"112","author":"Ekdawi","year":"1966","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004278.pub2-BIB0024|cit24","first-page":"1459","article-title":"A controlled trial of haloperidol in chronic schizophrenics","volume":"106","author":"Enoch","year":"1960","journal-title":"Journal of Mental Science (British Journal of Psychiatry from 1963)"},{"issue":"September","key":"10.1002\/14651858.CD004278.pub2-BIB0025|cit25","first-page":"31","article-title":"The treatment of chronic schizophrenia: intensive occupational therapy with and without chlorpromazine","volume":"23","author":"Fransella","year":"1960","journal-title":"Occupational Therapy"},{"issue":"8","key":"10.1002\/14651858.CD004278.pub2-BIB0026|cit26","first-page":"581","article-title":"Parenteral haloperidol in psychiatric emergencies. Double-blind comparison with chlorpromazine","volume":"38","author":"Gerstenzang","year":"1977","journal-title":"Diseases of the Nervous System"},{"issue":"9","key":"10.1002\/14651858.CD004278.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/00005053-198809000-00009","article-title":"High potency neuroleptics and violence in schizophrenics","volume":"176","author":"Herrera","year":"1988","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"2","key":"10.1002\/14651858.CD004278.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1017\/S0033291700030282","article-title":"Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measures","volume":"22","author":"Hogan","year":"1992","journal-title":"Psychological Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004278.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00004714-198406000-00003","article-title":"Neuroleptic drug-induced changes in platelet levels","volume":"4","author":"Holt","year":"1984","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD004278.pub2-BIB0030|cit30","first-page":"77","article-title":"Clozapine - antipsychotic activity in treatment-resistant schizophrenics","volume":"1","author":"Honigfeld","year":"1984","journal-title":"Advances in Therapy"},{"issue":"3","key":"10.1002\/14651858.CD004278.pub2-BIB0031|cit31","first-page":"181","article-title":"Comparison of the effects of chlorprothixene and haloperidol on hypothalamic function in patients with paranoid schizophrenia","volume":"19","author":"Horodnicki","year":"1985","journal-title":"Psychiatria Polska"},{"issue":"6","key":"10.1002\/14651858.CD004278.pub2-BIB0032|cit32","first-page":"276","article-title":"Treatment of chronic schizophrenic patients with haloperidol and chlorpromazine combined","volume":"10","author":"Jones","year":"1968","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"issue":"1","key":"10.1002\/14651858.CD004278.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/j.1552-4604.1981.tb01730.x","article-title":"Viloxazine and the depressed schizophrenic - methodological issues","volume":"21","author":"Kurland","year":"1981","journal-title":"Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD004278.pub2-BIB0034|cit34","first-page":"17","article-title":"Translation and application of the Simpson and Angus scale of extrapyramidal symptoms","volume":"19","author":"Lejoyeux","year":"1993","journal-title":"Encephale"},{"issue":"6","key":"10.1002\/14651858.CD004278.pub2-BIB0035|cit35","first-page":"279","article-title":"Evolution of depressive and psychotic symptomatology in hospitalised schizophrenic patients treated with neuroleptics (controlled study: haloperidol vs chlorpromazine)","volume":"11","author":"Lemp\u00e9ri\u00e8re","year":"1985","journal-title":"Encephale"},{"issue":"1","key":"10.1002\/14651858.CD004278.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/00048677309161478","article-title":"Haloperidol and chlorpromazine - a double-blind cross-over trial and clinical study in children and adolescents","volume":"7","author":"Lewis","year":"1973","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD004278.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/070674376901400412","article-title":"Integrated EEG. variability: drug effects in acute schizophrenics","volume":"14","author":"Marjerrison","year":"1969","journal-title":"Canadian Psychiatric Association Journal"},{"issue":"2","key":"10.1002\/14651858.CD004278.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1600-0447.1975.tb00220.x","article-title":"Implications of phenothiazine side effects: a study of antiparkinsonian agents in an older population","volume":"51","author":"Martin","year":"1975","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"4","key":"10.1002\/14651858.CD004278.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF00432759","article-title":"Prophylactic effect of neuroleptics in symptom-free schizophrenics","volume":"77","author":"Nishikawa","year":"1982","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD004278.pub2-BIB0040|cit40","first-page":"29","article-title":"Flupentixol decanoate versus other neuroleptics in chronic schizophrenia","volume":"35","author":"Palma Wenzel","year":"1997","journal-title":"Revista Chilena de Neuropsiquiatria"},{"issue":"1","key":"10.1002\/14651858.CD004278.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF00431103","article-title":"Bilateral skin conductance and the pupillary light dark reflex - manipulation by chlorpromazine, haloperidol, scopolamine, and placebo","volume":"73","author":"Patterson","year":"1981","journal-title":"Psychopharmacology"},{"issue":"16","key":"10.1002\/14651858.CD004278.pub2-BIB0042|cit42","first-page":"707","article-title":"Depot neuroleptics in the treatment of schizophrenia","volume":"115","author":"Schipper","year":"1971","journal-title":"Nederlands Tijdschrift Voor Geneeskunde"},{"issue":"2","key":"10.1002\/14651858.CD004278.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1600-0447.1993.tb03335.x","article-title":"Poor neuroleptic response in acutely exacerbated schizophrenic patients","volume":"87","author":"Shalev","year":"1993","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD004278.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00421013","article-title":"A longitudinal therapeutic comparison between two prototypic neuroleptics (haloperidol and chlorpromazine) in matched groups of schizophrenics. Nontherapeutic interactions with trihexyphenidyl. Theoretical implications for potency differences","volume":"43","author":"Singh","year":"1975","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD004278.pub2-BIB0045|cit45","first-page":"191","article-title":"Dysphoric response to neuroleptic treatment in schizophrenia and its prognostic significance","volume":"37","author":"Singh","year":"1976","journal-title":"Diseases of the Nervous System"},{"issue":"4","key":"10.1002\/14651858.CD004278.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00005053-197504000-00005","article-title":"Therapeutic reversal with benztropine in schizophrenics: practical and theoretical significance","volume":"160","author":"Singh","year":"1975","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"2","key":"10.1002\/14651858.CD004278.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00421012","article-title":"A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics","volume":"43","author":"Singh","year":"1975","journal-title":"Psychopharmacologia"},{"issue":"3","key":"10.1002\/14651858.CD004278.pub2-BIB0048|cit48","first-page":"124","article-title":"Computerized EEG profiles of haloperidol, chlorpromazine, clozapine and placebo in treatment resistant schizophrenia","volume":"18","author":"Small","year":"1987","journal-title":"Clinical Electroencephalography"},{"issue":"1","key":"10.1002\/14651858.CD004278.pub2-BIB0049|cit49","first-page":"24","article-title":"Comparative studies of the effects of perazine, fluphenazine, trifluoperazine, chlorpromazine and haloperidol on primary and deficit symptoms of paranoid schizophrenia","volume":"23","author":"Terminska","year":"1989","journal-title":"Psychiatria Polska"},{"key":"10.1002\/14651858.CD004278.pub2-BIB0050|cit50","first-page":"81","article-title":"The dopamine hypothesis of schizophrenia. Some direct observations","volume-title":"On the origin of schizophrenic psychoses","author":"Praag","year":"1975"},{"key":"10.1002\/14651858.CD004278.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1600-0447.1968.tb01996.x","article-title":"Experience with a new butyrophenone derivative (Buronil)","volume":"203","author":"Vangtorp","year":"1968","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"issue":"11","key":"10.1002\/14651858.CD004278.pub2-BIB0052|cit52","first-page":"12","article-title":"The relation of qeeg with the therapeutic effect of antipsychotic drugs","volume":"4","author":"Wang","year":"2000","journal-title":"Modern Rehabilitation"},{"issue":"3","key":"10.1002\/14651858.CD004278.pub2-BIB0053|cit53","first-page":"177","article-title":"An economic burden comparison of typical and atypical antipsychotic therapies for schizophrenia","volume":"35","author":"Yu","year":"2002","journal-title":"Chinese Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD004278.pub2-BIB0054|cit54","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000284.pub2","article-title":"Chlorpromazine versus placebo for schizophrenia","author":"Adams","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004278.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004278.pub2-BIB0056|cit56","first-page":"459","article-title":"Haloperidol: fifteen years of clinical experience","volume":"33","author":"Ayd","year":"1972","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD004278.pub2-BIB0057|cit57","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-662-12174-0","volume-title":"Kompendium der Psychiatrischen Pharmakotherapie","author":"Benkert","year":"2000"},{"key":"10.1002\/14651858.CD004278.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD004278.pub2-BIB0059|cit59","first-page":"405","article-title":"The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use","volume":"54","author":"Boissel","year":"1999","journal-title":"Therapie"},{"key":"10.1002\/14651858.CD004278.pub2-BIB0060|cit60","first-page":"1591","article-title":"Antipsychotic drugs","volume-title":"Comprehensive textbook of psychiatry","author":"Davis","year":"1989"},{"key":"10.1002\/14651858.CD004278.pub2-BIB0061|cit61","unstructured":"Deeks J Issues in the selection for meta-analyses of binary data Abstracts of 8th International Cochrane Colloquium; 2000 Oct 25-28th; Cape Town, South Africa 2000"},{"key":"10.1002\/14651858.CD004278.pub2-BIB0062|cit62","unstructured":"Delay J Deniker P Congres de medicins alienistes et neurologistes de France. Luxembourg 1952 479\/514"},{"key":"10.1002\/14651858.CD004278.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD004278.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004278.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD004278.pub2-BIB0066|cit66","volume-title":"ECDEU assessment manual for psychopharmacology","author":"Guy","year":"1976"},{"issue":"3","key":"10.1002\/14651858.CD004278.pub2-BIB0067|cit67","article-title":"Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]","author":"Higgins","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD004278.pub2-BIB0068|cit68","article-title":"Haloperidol versus placebo for schizophrenia (Cochrane review)","author":"Joy","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004278.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004278.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD004278.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004278.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1126\/science.1145194","article-title":"Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons","volume":"188","author":"Seeman","year":"1975","journal-title":"Science"},{"key":"10.1002\/14651858.CD004278.pub2-BIB0073|cit73","unstructured":"The Cochrane Collaboration The Cochrane Library (database on disk and CD-ROM) Oxford Update Software"},{"issue":"5","key":"10.1002\/14651858.CD004278.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3310\/hta3050","article-title":"Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review","volume":"3","author":"Ukoumunne","year":"1999","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD004278.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s002130100711","article-title":"Drop-out rates in randomised antipsychotic drug trials","volume":"155","author":"Wahlbeck","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD004278.pub2-BIB0076|cit76","volume-title":"World health report","author":"World Health Organisation","year":"2001"},{"key":"10.1002\/14651858.CD004278.pub2-BIB0077|cit77","unstructured":"World Health Organisation Essential drugs WHO Drug Information 2002 131 58"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD004278.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T09:17:37Z","timestamp":1730452657000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004278.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Schizophrenia Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2008,1,23]]},"references-count":77,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004278.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,23]]}}}